Investment Analysis

Showing 3549 articles
Business

Retirement Dilemma: To Borrow or to Sell? A 70-Something Couple Weighs $60K Home Repair Options

A retired couple in their early 70s, living on Social Security and pensions with a paid-off home and nearly $1 million in investments, faces a common but critical financial crossroads: should they fund $50,000-$60,000 in home renovations by taking out a loan or by selling stocks? Experts weigh the tax implications, market risks, and lifestyle factors unique to later-life financial planning.

Business

Giverny Capital Exits Credit Acceptance as Market Focus Shifts to AI

Investment firm Giverny Capital has sold its position in auto-finance provider Credit Acceptance Corporation, citing a challenging market environment dominated by AI hype and large-cap tech outperformance. The move highlights a broader divergence between fundamental business performance and current investor sentiment.

Business

Three Sub-$50 Stocks Investors Should Approach With Caution

While stocks priced between $10 and $50 can appear to offer an attractive balance of accessibility and maturity, not all are sound investments. We examine three companies in this range whose valuations and business prospects raise significant red flags for discerning investors.

Business

ServiceNow Bets Big on AI and Buybacks to Reignite Growth Narrative

Amid a sharp stock decline, ServiceNow's strong Q4 2025 results and a $9.5 billion buyback signal management's confidence. The deeper integration of Anthropic's Claude AI across critical sectors like healthcare and finance is positioned as the central catalyst for its long-term transformation, even as investors question the ROI of massive AI investments.

Business

Guardian Pharmacy Services: Is the Stock Fairly Valued After Recent Gains?

A deep dive into Guardian Pharmacy Services (NYSE:GRDN) using a discounted cash flow model suggests its current share price is hovering close to its estimated intrinsic value. While the analysis provides a quantitative benchmark, investors are cautioned that valuation is just one piece of the puzzle in a complex and regulated healthcare sector.

Business

Sealed Air's Rally Faces Headwinds: Analysts Flag Growth Concerns, Suggest Alternative Play

Despite a 44.5% surge in the past six months, driven by solid quarterly results, analysts are sounding a note of caution on Sealed Air (SEE). Concerns over stagnant sales volume, slowing revenue forecasts, and declining returns on capital suggest the packaging giant's momentum may be hard to sustain. We examine the risks and highlight a more compelling investment opportunity in the industrial sector.